
    
      This is a prospective, multicenter open-label study in adults with CF who are colonized with
      M. avium complex and/or M. abscessus complex.

      Subjects will receive two 5-day infusion cycles of IV gallium. The study will evaluate the
      safety and antimycobacterial effect of two 5-day infusions of IV gallium.
    
  